Gelonghui, March 20 | Berry Genomics and Celi Medical are on the 3rd board. Runda Healthcare hit a rise or fall, while Wanda Information, Hongbo Pharmaceuticals, and Sichuang Medical Benefits followed suit. According to the news, Novo Nordisk Foundation announced a few days ago that it has reached an agreement with Nvidia to build a superAI computer called “GEFION” for the Nordic country Denmark to lead the country into the AI field. Furthermore, at its annual health event “The Check Up,” Google announced a series of new initiatives to apply artificial intelligence (AI) models to the healthcare industry.
A股异动丨AI医疗概念反复活跃 贝瑞基因3连板
A-share changes丨The AI medical concept is repeatedly active, and the Berry gene is linked to 3 links
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Statement
This page is machine-translated. Futubull tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation.
Write a comment
0 0 0
LikeLoveLaughing CryRespectEmmSadAngry
Tap to Select a Mood
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
Use the share button in your browser
to share the page with your friends
Tap here to share
No comments yet. Write one.